Nir Drayman

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones et al. · Science · 2021 · 246 citations · Full text

A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets

Yadi Zhou, Yuan Liu, Shagun Gupta et al. · Nature Biotechnology · 2022 · 183 citations · Full text

Covid-19 Pandemic, Viral Pathogenesis, Immunology +5

An Identical miRNA of the Human JC and BK Polyoma Viruses Targets the Stress-Induced Ligand ULBP3 to Escape Immune Elimination

Yoav Bauman, Daphna Nachmani, Alon Vitenshtein et al. · Cell Host & Microbe · 2011 · 174 citations · Full text

Immunology, Antiviral Response, Pathology +10

HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations

Nir Drayman, Parthiv Patel, Luke Vistain et al. · eLife · 2019 · 164 citations · Full text

Viral Replication, Viral Pathogenesis, Immunology +17

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

Long C. Nguyen, Dongbo Yang, Vlad Nicolaescu et al. · Science Advances · 2022 · 135 citations · Full text

Inflammation, Host Er Stress, Lung Epithelial Cells +13